You are here

vaccines

As UK awaits first Covid-19 vaccine doses, Fauci and others criticize its 'hasty' decision

As UK awaits first Covid-19 vaccine doses, Fauci and others criticize its 'hasty' decision

Endpoints

Flag link:

‘There absolutely will be a black market’: How the rich and privileged can skip the line for Covid-19 vaccines

‘There absolutely will be a black market’: How the rich and privileged can skip the line for Covid-19 vaccines

Stat

Flag link:

A closer look at the behind-the-scenes companies moving coronavirus vaccines around the world

A closer look at the behind-the-scenes companies moving coronavirus vaccines around the world

BioPharma Dive

Flag link:

ICMRA: Continue COVID vaccine trials "as long as is feasible"

ICMRA: Continue COVID vaccine trials "as long as is feasible"

RAPS.org

clinical trials

Flag link:

Merck Sells Stake in Moderna as Vaccine Gets FDA Review

Merck Sells Stake in Moderna as Vaccine Gets FDA Review

Bloomberg

Moderna Therapeutics

Flag link:

U.K. approves Pfizer’s Covid-19 vaccine, putting pressure on FDA

U.K. approves Pfizer’s Covid-19 vaccine, putting pressure on FDA

Stat

Flag link:

Pfizer, Moderna apply for EMA authorization; Janssen's candidate begins rolling review

Pfizer, Moderna apply for EMA authorization; Janssen's candidate begins rolling review

RAPS.org

Moderna Therapeutics

Emergency Use Authorization

Flag link:

Convincing People to Get COVID-19 Vaccinations Will Likely Require Anecdotes and Data

Convincing People to Get COVID-19 Vaccinations Will Likely Require Anecdotes and Data

BioSpace

Flag link:

FDA chief called to West Wing to explain delay in approving COVID vaccine

FDA chief called to West Wing to explain delay in approving COVID vaccine

Axios

Flag link:

Here's Why Johnson & Johnson Is Still in the Coronavirus Vaccine Race

Here's Why Johnson & Johnson Is Still in the Coronavirus Vaccine Race

Motley Fool

Moderna Therapeutics

Flag link:

Moderna's Coronavirus Vaccine to Be Reviewed by FDA Advisory Committee on Dec. 17

Moderna's Coronavirus Vaccine to Be Reviewed by FDA Advisory Committee on Dec. 17

Motley Fool

Moderna Therapeutics

Flag link:

Novavax, swamped with FDA's manufacturing 'questions,' hopes for U.S. coronavirus shot trial by the end of the year

Novavax, swamped with FDA's manufacturing 'questions,' hopes for U.S. coronavirus shot trial by the end of the year

Fierce Pharma

drug manufacturing

clinical trials

Flag link:

AstraZeneca nears temporary OK for COVID-19 vaccine, plots extra trial

AstraZeneca nears temporary OK for COVID-19 vaccine, plots extra trial

Fierce Biotech

clinical trials

Flag link:

Moderna's Coronavirus Vaccine Candidate 100% Effective at Preventing Severe COVID-19

Moderna's Coronavirus Vaccine Candidate 100% Effective at Preventing Severe COVID-19

Motley Fool

Moderna Therapeutics

clinical trials

Flag link:

Moderna takes its Covid-19 vaccine to the FDA

Moderna takes its Covid-19 vaccine to the FDA

EP Vantage

Moderna Therapeutics

clinical trials

Emergency Use Authorization

Flag link:

Why AstraZeneca's Potential Vaccine Is More Exciting Than You Think

Why AstraZeneca's Potential Vaccine Is More Exciting Than You Think

Motley Fool

clinical trials

Flag link:

Go or no go? The year ends with Covid-19 vaccine approvals in sight

Go or no go? The year ends with Covid-19 vaccine approvals in sight

EP Vantage

Flag link:

AZ mulls trial of new COVID-19 vaccine dose as UK regulator begins review

AZ mulls trial of new COVID-19 vaccine dose as UK regulator begins review

Pharmaforum

clinical trials

Flag link:

BioNTech & InstaDeep launch AI innovation lab for next-generation vaccines and biopharmaceuticals

BioNTech & InstaDeep launch AI innovation lab for next-generation vaccines and biopharmaceuticals

Biopharma Reporter

artificial intelligence

Flag link:

Brexit could hinder access to coronavirus vaccines, says pharma group

Brexit could hinder access to coronavirus vaccines, says pharma group

Pharmaforum

Flag link:

Pages